Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Pre-B Lymphocyte 3 (VPREB3) (Middle Region) Peptid

VPREB3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5513127

Kurzübersicht für Pre-B Lymphocyte 3 (VPREB3) (Middle Region) Peptid (ABIN5513127)

Target

VPREB3 (Pre-B Lymphocyte 3 (VPREB3))

Spezies

Human

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    TIRDYGVSWY QQRAGSAPRY LLYYRSEEDH HRPADIPDRF SAAKDEAHNA

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-VPREB3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    VPREB3 (Pre-B Lymphocyte 3 (VPREB3))

    Hintergrund

    The protein encoded by this gene is the human homolog of the mouse VpreB3 (8HS20) protein, and is specifically expressed in cell lines representative of all stages of B-cell differentiation. It is also related to VPREB1 and other members of the immunoglobulin supergene family. This protein associates with membrane mu heavy chains early in the course of pre-B cell receptor biosynthesis. The precise function of the protein is not known, but it may contribute to mu chain transport in pre-B cells.

    Alias Symbols: VPREB3, UNQ355/PRO619,

    Protein Size: 123

    Gen-ID

    29802

    NCBI Accession

    NP_037510

    UniProt

    Q9UKI3
Sie sind hier:
Chat with us!